Jeanne-pierre Cazenave

Jeanne-pierre Cazenave's AcademicInfluence.com Rankings

Philosophy

#7638

World Rank

#10879

Historical Rank

Ontology

#81

World Rank

#91

Historical Rank

Logic

#4685

World Rank

#6006

Historical Rank

philosophy Degrees

Jeanne-pierre Cazenave

Biology

#10324

World Rank

#13644

Historical Rank

Biochemistry

#1628

World Rank

#1761

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Jeanne-pierre Cazenave's Degrees

PhD Biochemistry University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Jeanne-pierre Cazenave Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jeanne-pierre Cazenave's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. (1999) (470)
Long-Term Antithrombotic Protection by in Vivo Depletion of Platelet Glycoprotein VI in Mice (2001) (356)
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells (1997) (316)
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. (2003) (314)
Endotoxin‐free heat‐shock protein 70 fails to induce APC activation (2002) (274)
The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation. (1998) (258)
Assistance of Microbial Glycolipid Antigen Processing by CD1e (2005) (253)
A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. (1999) (232)
Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. (1977) (231)
A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo (2003) (222)
Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. (1979) (221)
Effects on platelet function of removal of platelet sialic acid by neuraminidase. (1975) (210)
Preparation of washed platelet suspensions from human and rodent blood. (2004) (207)
Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. (2002) (186)
Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. (1986) (185)
Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. (2007) (181)
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology (2010) (169)
Adherence of platelets to a collagen-coated surface: development of a quantitative method. (1973) (164)
Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. (1985) (158)
Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. (2001) (158)
Rapid Isolation of Human Endothelial Cells from Whole Blood Using S-Endo1 Monoclonal Antibody Coupled to Immuno-Magnetic Beads: Demonstration of Endothelial Injury after Angioplasty (1992) (151)
The P2Y1 receptor, necessary but not sufficient to support full ADP‐induced platelet aggregation, is not the target of the drug clopidogrel (1998) (148)
Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) (1998) (142)
In Vitro and in Vivo Functions of Thrombin-Treated Platelets (1976) (141)
Differential Involvement of the P2Y1 and P2Y12 Receptors in Platelet Procoagulant Activity (2003) (140)
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study. (2008) (139)
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. (1999) (138)
MRS2500 [2-Iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate], a Potent, Selective, and Stable Antagonist of the Platelet P2Y1 Receptor with Strong Antithrombotic Activity in Mice (2006) (134)
Epinephrine potentiates human platelet activation but is not an aggregating agent. (1988) (134)
A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation. (1992) (133)
The human platelet ADP receptor activates Gi2 proteins. (1995) (132)
Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. (2001) (125)
Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set (2005) (121)
Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. (1993) (118)
Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. (1991) (118)
ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. (2000) (117)
Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion (2009) (116)
The P2Y12 receptor induces platelet aggregation through weak activation of the αIIbβ3 integrin – a phosphoinositide 3‐kinase‐dependent mechanism (2001) (114)
Thin-layer chromatography of human platelet phospholipids with fatty acid analysis. (1987) (107)
Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. (2009) (105)
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment (2008) (105)
Mono-allelic amplification of exons 2-4 using allele group-specific primers for sequence-based typing (SBT) of the HLA-A, -B and -C genes: preparation and validation of ready-to-use pre-SBT mini-kits. (2003) (102)
ADP Plays a Key Role in Thrombogenesis in Rats (1988) (102)
Signaling Role for Phospholipase Cγ2 in Platelet Glycoprotein Ibα Calcium Flux and Cytoskeletal Reorganization (2003) (99)
Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. (2001) (99)
Inhibition of localized thrombosis in P2Y1‐deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist (2003) (96)
Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. (1996) (94)
Importance of Platelet Phospholipase Cγ2 Signaling in Arterial Thrombosis as a Function of Lesion Severity (2005) (94)
Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. (1987) (93)
Characterization of CD1e, a Third Type of CD1 Molecule Expressed in Dendritic Cells* (2000) (92)
Detection of Toxoplasma gondii in aqueous humour by the polymerase chain reaction. (1993) (91)
Ticlopidine and Clopidogrel (SR 25990C) Selectively Neutralize ADP Inhibition of PGE1-Activated Platelet Adenylate Cyclase in Rats and Rabbits (1991) (90)
Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients (1995) (90)
Lupus-Like Anticoagulants, Modulation of the Protein C Pathway and Thrombosis (1987) (89)
Inhibition of Platelet Functions and Thrombosis through Selective or Nonselective Inhibition of the Platelet P2 Receptors with Increasing Doses of NF449 [4,4′,4″,4″′-(Carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic Acid Octasodium Salt] (2005) (89)
Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens). (1987) (89)
Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. (1982) (88)
Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus (2004) (88)
Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. (1993) (88)
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. (2002) (84)
Membrane and soluble Fc gamma RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. (1995) (83)
Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3‐year period (2011) (81)
Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: Structure-activity relationships (1982) (80)
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. (1984) (79)
Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus. (2014) (79)
A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. (1993) (79)
Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. (2003) (77)
Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome (2009) (77)
Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells. (1997) (77)
Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. (1980) (77)
The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man. (1990) (76)
Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells. (1998) (75)
Differential Regulation and Relocalization of the Platelet P2Y Receptors after Activation: A Way to Avoid Loss of Hemostatic Properties? (2005) (75)
The Cellular Pathway of CD1e in Immature and Maturing Dendritic Cells (2005) (74)
Human epidermal Langerhans cells express only the 40-kilodalton Fc gamma receptor (FcRII). (1990) (73)
Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte‐derived but not epidermal dendritic cells (2002) (73)
Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro (2003) (73)
Clq inhibition of the interaction of collagen with human platelets. (1976) (72)
The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. (1990) (71)
Active γ-carboxylated human factor IX expressed using recombinant DNA techniques (1985) (70)
The αIIbβ3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+cord blood cells to megakaryocytes (2000) (70)
The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism. (2001) (69)
Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor (2004) (68)
CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. (2001) (68)
Von Willebrand factor in diabetic angiopathy. (1998) (68)
Reduced Atherosclerotic Lesions in P2Y1/Apolipoprotein E Double-Knockout Mice: The Contribution of Non–Hematopoietic-Derived P2Y1 Receptors (2008) (67)
The P2Y1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice (2005) (67)
Lineage‐specific overexpression of the P2Y1 receptor induces platelet hyper‐reactivity in transgenic mice (2003) (66)
Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studies. (1990) (65)
A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies (2007) (65)
Bacterial contamination in platelet concentrates (2014) (65)
Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link? (1999) (64)
Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. (1992) (64)
Major Contribution of the P2Y1 Receptor in Purinergic Regulation of TNF&agr;-Induced Vascular Inflammation (2011) (63)
The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented (2004) (63)
Adhesive and/or signaling functions of CD44 isoforms in human dendritic cells. (1998) (62)
The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae. (1980) (60)
Quantitative radioisotopic measurement and scanning electron microscopic study of platelet adherence to a collagen-coated surface and to subendothelium with a rotating probe device. (1979) (60)
Arterial Thrombosis and Protein S Deficiency (1989) (59)
Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. (1994) (58)
Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments. (1980) (57)
Microgravity modifies protein kinase C isoform translocation in the human monocytic cell line U937 and human peripheral blood T‐cells (2002) (56)
Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation (2013) (56)
A method for the rapid isolation of human epidermal Langerhans cells using immunomagnetic microspheres. (1988) (53)
Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity. (1983) (52)
The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex. (1986) (52)
Identification of a novel 14-3-3ζ binding site within the cytoplasmic tail of platelet glycoprotein Ibα (2004) (51)
Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. (1997) (51)
Inhibition of platelet adherence to damaged surface of rabbit aorta. (1975) (51)
Inheritance of the human platelet alloantigen, PlA1, in type I Glanzmann's thrombasthenia. (1981) (51)
[Platelet aggregation: a tool for clinical investigation and pharmacological study. Methodology]. (1983) (50)
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment (2010) (48)
Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP) (2002) (48)
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers (2008) (48)
Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients (1996) (47)
ADP receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes. (1992) (46)
Alpha IIb beta 3 integrin dissociation induced by EDTA results in morphological changes of the platelet surface-connected canalicular system with differential location of the two separate subunits (1993) (46)
Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice (2010) (45)
ADP induced blood platelet activation: a review. (1991) (45)
A general approach toward the synthesis of C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 3',5'-bisphosphate C-nucleotide analogues as the first reported in vivo stable P2Y(1)-receptor antagonists. (2002) (44)
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. (1997) (44)
Quantitative analysis of vitamin E, cholesterol and phospholipid fatty acids in a single aliquot of human platelets and cultured endothelial cells. (1997) (43)
Rab11A controls the biogenesis of Birbeck granules by regulating Langerin recycling and stability. (2007) (43)
Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. (1994) (43)
Simultaneous determination of homologues of vitamin E and coenzyme Q and products of alpha-tocopherol oxidation. (1998) (43)
The effect of flavonoids on blood-vessel wall interactions. (1988) (43)
Prostaglandins I2 and E1 reduce rabbit and human platelet adherence without inhibiting serotonin release from adherent platelets. (1979) (42)
Inhibition of platelet adherence to a collagen-coated surface by nonsteroidal anti-inflammatory drugs, pyrimido-pyrimidine and tricyclic compounds, and lidocaine. (1974) (42)
Role of the intracellular domains of GPIb in controlling the adhesive properties of the platelet GPIb/V/IX complex. (2003) (40)
Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities (1993) (40)
Fc receptors of human Langerhans cells. (1990) (40)
Reproduction of Langerin/CD207 traffic and Birbeck granule formation in a human cell line model. (2004) (39)
The alpha(IIb)beta(3) integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34(+) cord blood cells to megakaryocytes. (2000) (39)
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization. (1987) (39)
Platelet deposition in a capillary perfusion model: quantitative and morphological aspects. (1988) (38)
Long-Chain n-3 Fatty Acids Specifically Affect Rat Coagulation Factors Dependent on Vitamin K: Relation to Peroxidative Stress (2001) (38)
Cutting Edge: A Naturally Occurring Mutation in CD1e Impairs Lipid Antigen Presentation1 (2008) (38)
Adhesion of human breast cancer cell line MCF‐7 to human vascular endothelial cells in culture. enhancement by activated platelets (1987) (38)
Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate. (1986) (37)
Blood-surface interactions : biological principles underlying haemocompatibility with artificial materials (1986) (37)
Adenosine diphosphate(ADP) does not induce thromboxane A2 generation in human platelets. (2002) (36)
Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926. (1989) (36)
Appearance of Birbeck granule-like structures in anti-T6 antibody-treated human epidermal Langerhans cells. (1988) (36)
CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring (2009) (36)
Evidence for Humoral Rejection of a Pancreatic Islet Graft and Rescue with Rituximab and IV Immunoglobulin Therapy (2009) (35)
Functional characterization of the human platelet glycoprotein V gene promoter: A specific marker of late megakaryocytic differentiation. (1999) (35)
Heparin inhibits thrombin binding to rabbit thoracic aorta endothelium. (1980) (35)
Inefficient protection of human TAP‐deficient fibroblasts from autologous NK cell‐mediated lysis by cytokines inducing HLA class I expression (1999) (35)
Synthesis and adsorption of a poly(N-acetylethyleneimine)-polyethyleneoxide-poly (N-acetylethyleneimine) triblock-copolymer at a silica/solution interface. Influence of its preadsorption on platelet adhesion and fibrinogen adsorption. (1989) (35)
Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. (1995) (35)
A Leu7Pro mutation in the signal peptide of platelet glycoprotein (GP)IX in a case of Bernard–Soulier syndrome abolishes surface expression of the GPIb–V–IX complex (2002) (34)
Old and new natural products as the source of modern antithrombotic drugs. (1991) (34)
HLA-DQA2 and HLA-DQB2 Genes Are Specifically Expressed in Human Langerhans Cells and Encode a New HLA Class II Molecule (2012) (34)
A novel missense mutation shows that GPIbbeta has a dual role in controlling the processing and stability of the platelet GPIb-IX adhesion receptor. (2003) (34)
Use of polymerase chain reaction to detect Toxoplasma. (1991) (33)
Characterization of megakaryocyte development in the native bone marrow environment. (2012) (33)
Culture of human vascular endothelial cells on a positively charged polystyrene surface, primaria: comparison with fibronectin-coated tissue culture grade polystyrene. (1989) (33)
Release of Fc gamma RIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant Fc gamma RIIa2. (1995) (32)
The effects of flavonoids on cyclic nucleotide phosphodiesterases. (1986) (32)
CD1 expression is not affected by human peptide transporter deficiency. (1994) (32)
Effects of Cephalothin and Penicillin G on Platelet Function in Vitro (1977) (31)
The P 2 Y 1 Receptor Is Necessary for Adenosine 5 8-Diphosphate – Induced Platelet Aggregation (1998) (31)
Competitive adsorption of human immunoglobulin G and albumin: consequences for structure and reactivity of the adsorbed layer. (1992) (31)
Release of soluble Fc gamma RII/CD32 molecules by human Langerhans cells: a subtle balance between shedding and secretion? (1992) (31)
Kinetics of exchange processes in the adsorption of proteins on solid surfaces. (1994) (31)
Identification of a novel 14-3-3zeta binding site within the cytoplasmic tail of platelet glycoprotein Ibalpha. (2004) (30)
Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation in vivo and its prevention by heparin. (1979) (30)
High stability of blood samples for flow cytometric analysis of VASP phosphorylation to measure the clopidogrel responsiveness in patients with coronary artery disease (2005) (30)
ATPase and morphologic changes in Langerhans cells induced by epicutaneous application of a sensitizing dose of DNFB. (1989) (30)
Purinergic receptors on blood platelets. (1996) (30)
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosis. (1999) (30)
Prevalence and significance of anticardiolipin antibodies in Crohn's disease (1994) (29)
Significance of Diminished Factor XIII in Crohn's Disease (1998) (29)
Effects of an extract of human brain containing growth factor activity on the proliferation of human vascular endothelial cells in primary culture (1984) (28)
Choosing a Host Cell for Active Recombinant Factor VIII Production Using Vaccinia Virus (1987) (28)
Soluble CD16/Fc gamma RIII induces maturation of dendritic cells and production of several cytokines including IL-12. (1997) (28)
Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. (1992) (28)
Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels (2001) (27)
T6 positive cells in the peripheral blood of burn patients: are they Langerhans cells precursors? (1988) (27)
Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo. (1982) (27)
The effect of acetylsalicylic acid and indomethacin on rabbit platelet adherence to collagen and the subendothelium in the presence of a low or high hematocrit. (1978) (27)
Serotonin transport and storage in rabbit blood platelets--the effects of reserpine and imipramine. (1977) (27)
Platelet adherence to the vessel wall and to collagen-coated surfaces. (1978) (26)
A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B. (1986) (26)
Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke (2005) (26)
Hirudin and heparin enable efficient megakaryocyte differentiation of mouse bone marrow progenitors. (2012) (25)
Platelet phospholipids are differentially protected against oxidative degradation by plasmalogens (2002) (25)
Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor (1990) (25)
Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel: a report of three cases (2007) (25)
Design of clinical trials to evaluate the efficacy of platelet transfusion: the euroSPRITE trial for components treated with Helinx technology. (2001) (24)
Novel point mutations leading to type 1 antithrombin deficiency and thrombosis (1991) (23)
Prostacyclin (epoprostenol) as the sole antithrombotic agent in postdilutional hemofiltration. (1988) (23)
Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model (2002) (23)
Polyindolinic alkaloids from Psychotria forsteriana. Potent inhibitors of the aggregation of human platelets. (1985) (22)
Plasma glycoprotein V levels in the general population: Normal distribution, associated parameters and implications for clinical studies (2006) (22)
The Antithrombotic Activity of EP224283, a Neutralizable Dual Factor Xa Inhibitor/Glycoprotein IIbIIIa Antagonist, Exceeds That of the Coadministered Parent Compounds (2011) (22)
Differential Involvement of the P 2 Y 1 and P 2 Y 12 Receptors in Platelet Procoagulant Activity (2003) (22)
Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis. (1990) (22)
Pathogen inactivation of platelet concentrates (2010) (21)
Platelet function: aggregation by PAF or sequestration in lung is not modified during immediate or late allergen-induced bronchospasm in man. (1989) (21)
Biosynthesis and intracellular post-translational processing of normal and mutant platelet glycoprotein GPIb-IX. (2001) (21)
Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency (2005) (20)
Angiogenesis inhibitor SR 25989 upregulates thrombospondin-1 expression in human vascular endothelial cells and foreskin fibroblasts. (1997) (20)
Detection and quantification of secreted soluble FcγRIIA in human sera by an enzyme-linked immunosorbent assay (1993) (20)
Kinetics of Gene Induction After FcεRI Ligation of Atopic Monocytes Identified by Suppression Subtractive Hybridization1 (2002) (20)
Biochemical and molecular basis of Bernard-Soulier syndrome: a review. (1995) (20)
Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet shape change and clot retraction. (1974) (20)
Platelets in Thrombotic and Non-thrombotic Disorders: Pharmacology of ticlopidine and clopidogrel (2002) (20)
Interaction of Human Epidermal Langerhans Cells with HIV‐1 Viral Envelope Proteins (gp 120 and gp 160s) Involves a Receptor‐mediated Endocytosis Independent of the CD4 T4A Epitope (1991) (19)
Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques. (2002) (19)
[Serum cardiolipin antibodies in patients with alcoholic cirrhosis]. (1996) (18)
Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study. (1998) (18)
Control of the Intracellular Pathway of CD1e (2008) (18)
Ultrastructural similarities between epidermal Langerhans cell Birbeck granules and the surface-connected canalicular system of EDTA-treated human blood platelets. (1991) (18)
A null HLA-A*68 allele in a bone marrow donor. (1999) (17)
Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides. (1989) (17)
Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. (1998) (17)
Prevention of transfusion‐transmitted cytomegalovirus (CMV) infection: Standards of care (2014) (17)
Epoetin alfa facilitates presurgical autologous blood donation in non-anaemic patients scheduled for orthopaedic or cardiovascular surgery. (1997) (17)
Effects of sodium periodate on platelet functions. (1976) (17)
Adduct formation between soluble fibrin monomers and elastin. (1987) (17)
Production and evaluation of recombinant hirudin. (1989) (17)
Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin. (1979) (16)
Assessment of complement activation during membrane‐based plasmapheresis procedures (2004) (16)
9 Anti-platelet drugs: do they affect megakaryocytes? (1997) (16)
Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers. (1997) (16)
Experimental modification of platelet survival. (1977) (16)
Opposing effects of heparin with TGF‐β or aFGF during repair of a mechanical wound of human endothelium. Influence of cAMP on cell migration (1992) (16)
Comparative effectiveness of plasma prepared with amotosalen‐UVA pathogen inactivation and conventional plasma for support of liver transplantation (2015) (15)
Functions of Fc receptors on human dendritic Langerhans cells. (1997) (15)
Diets enriched in (n-3) fatty acids affect rat coagulation factors dependent on vitamin K. (1998) (15)
Two independent domains of factor VIII co-expressed using recombinant vaccinia viruses have procoagulant activity. (1987) (15)
Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques. (1985) (15)
Electrophoretic studies on molecular defects of von Willebrand factor and platelet glycoprotein IIb-IIIa with antibodies produced in egg yolk from laying hens. (1992) (14)
Drug effects on platelet adherence to collagen and damaged vessel walls. (1978) (14)
Measurement and manipulation of [Ca2+]i in suspensions of platelets and cell cultures. (2004) (14)
111Indium Labelling of Human Washed Platelets; Kinetics and in Vivo Sequestration Sites (1984) (14)
Modulation by cytokines of leukocyte-endothelial cell interactions. Implications for thrombosis. (1990) (14)
Anti-platelet drugs: do they affect megakaryocytes? (1997) (14)
Mitogenic activity on human arterial smooth muscle cells is increased in the plasma of patients undergoing hemodialysis with cuprophane membranes. (1989) (13)
Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation (1986) (13)
Effect of heparin and thrombin on platelet adherence to the surface of rabbit aorta. (1978) (13)
The effect of a platelet-derived growth factor on the proliferation of rabbit arterial smooth muscle cells in tissue culture. (1979) (13)
Rat platelets contain glycosylated and non-glycosylated forms of platelet factor 4. Identification and characterization by mass spectrometry. (1994) (13)
Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura (2018) (12)
Fodel, Photoimageable Materials - a Thick Film Solution for High Density Multichip Modules (1993) (12)
Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease. (1973) (12)
Caffeine does not cause override of the G2/M block induced by UVc or gamma radiation in normal human skin fibroblasts (2000) (12)
Influence of a preadsorbed terpolymer on human platelet accumulation, fibrinogen adsorption, and ex vivo blood activation in hemodialysis hollow fibers. (1992) (12)
Antiphospholipid antibodies in inflammatory bowel disease (1995) (12)
In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site. (1990) (12)
In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set (2006) (12)
Platelet shape change and protein phosphorylation induced by ADP and thrombin are not sensitive to short periods of microgravity. (1993) (11)
Diets rich in saturated n-9 and n-3 fatty acids differentially affect the fatty acid composition of phospholipids and function of rat platelets. (1996) (11)
Biosynthesis and intracellular post-translational processing of normal and mutant platelet glycoprotein GPIb-IX (2001) (11)
[Direct detection of toxoplasma in the aqueous humor by gene amplification]. (1991) (11)
Improvement of rDNA‐based PCR assay to detect Toxoplasma (1993) (11)
In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen (2004) (11)
Logistics of platelet concentrateses (2007) (11)
Leukodepletion of platelet concentrates and plasma collected with haemonetics MCS+ apheresis system. Experience of EFS-Alsace. (2001) (10)
Use of tandem Biacore-mass spectrometry to identify platelet membrane targets of novel monoclonal antibodies. (2009) (10)
Identification of platelet factor 4 and β‐thromboglobulin by profiling and liquid chromatography tandem mass spectrometry of supernatant peptides in stored apheresis and buffy‐coat platelet concentrates (2007) (10)
Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples (2010) (10)
Adrenaline Activates Human Platelets But Does Not Cause Primary Aggregation If Thrombin Generation Is Inhibited By Hirudin (1981) (9)
Possible mechanism of action of CD1a antigens. (1990) (9)
One-step assay for the determination of free protein S antigen in plasma using real-time biospecific interaction analysis. (1998) (9)
Hepatitis A in French Hemophiliacs (1994) (9)
Lipid composition of blood platelets and erythrocytes of southern elephant seal (Mirounga leonina) and antarctic fur seal (Arctocephalus gazella). (2000) (9)
Antiplatelet therapy in the prevention of ischaemic stroke. (1994) (9)
Development and validation of a genotyping kit for the eight principal human platelet alloantigen systems. (2000) (9)
cADP-ribose formation by blood platelets is not responsible for intracellular calcium mobilization. (1998) (9)
The treatment of deep vein thrombosis with continuous intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study. (1996) (9)
[Hematologic features in imported malaria. Value for the diagnosis of forms with low parasitemia]. (1991) (9)
In vitro interactions between human breast cancer cells MCF-7 and human blood platelets. (1987) (9)
Key Role of the P2Y1 Receptor in Tissue Factor–Induced Thrombin-Dependent Acute Thromboembolism: Studies in P2Y1-Knockout Mice and Mice Treated With a P2Y1 Antagonist (2001) (9)
Presence of functional P2T and P2U purinoceptors on the human megakaryoblastic cell line, Meg-01 characterization by functional and binding studies. (1995) (9)
Carrier detection in hemophilia using pedigree analysis coagulation tests and DNA probes. (1989) (8)
[Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety]. (2011) (8)
Variation in von Willebrand's Factor according to the treatment of acute myocardial infarction: physiopathological and clinical implications. (1994) (8)
A high concentration of ADP induces weak platelet granule secretion independently of aggregation and thromboxane A2 production (2007) (8)
Regulation of CD44 isoform expression and CD44-mediated signaling in human dendritic cells. (1997) (8)
Interactions of blood with surfaces: hemocompatibility and thromboresistance of biomaterials. (1988) (8)
Common intragenic and extragenic polymorphisms of blood coagulation factors VIII and IX are different in Chinese and Caucasian populations (1990) (8)
Mixed technologies for microwave multichip module (MMCM) applications-a review (1995) (8)
Soluble Fcgamma receptor, Fc gammaRIIa2, is present in two forms in human serum and is increased in patients: with stage C chronic lymphocytic leukemia. (1997) (8)
[Biological manifestations of a prethrombotic state in developmental Crohn's disease]. (1990) (8)
[Quantitative bacteriological evaluation of a method for skin disinfection in blood donors]. (1997) (7)
Biocompatibility and interfacial phenomena (1985) (7)
Platelet adhesion to surfaces (1993) (7)
Naftazone accelerates human saphenous vein endothelial cell proliferation in vitro. (1995) (7)
Common characteristics of the human and rhesus macaque CD1e molecules: conservation of biochemical and biological properties during primate evolution (2003) (7)
Effects of Penicillin G and Cephalothin on Platelet Function in Vivo (1976) (7)
Biosynthesis of platelet glycoprotein V expressed as a single subunit or in association with GPIb-IX. (2004) (7)
Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids. (1988) (7)
Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR 1-Activating Peptide Through the Late Activation of Phosphoinositide 3-Kinase (1999) (7)
Platelets in Thrombotic and Non-thrombotic Disorders: Platelet receptors: ADP (2002) (7)
Reactivity of Antibodies on Antigens Adsorbed on Solid Surfaces (1995) (7)
PF4 inhibits thrombin-stimulated MMP-1 and MMP-3 metalloproteinase expression in human vascular endothelial cells. (1997) (7)
Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability. (1992) (7)
αIIBβ3 Integrin Dissociation Induced by EDTA Results in Formation of Birbeck Granule-Like Structures in Human Blood Platelets (1992) (6)
The assembly of CD1e is controlled by an N-terminal propeptide which is processed in endosomal compartments. (2009) (6)
Effect of reserpine on adenosive uptake and metabolism, and subcellular transport of platelet adenosine triphosphate in washed rabbit platelets. (1977) (6)
Comparison of the Antithrombotic Effects of Heparin, Hirudin and Clopidogrel according to the Nature of the Thrombogenic Surface in an Arterioarterial Shunt in Rats (1999) (6)
Clinical Experience with Pathogen Inactivation of Platelet Components for Transfusion Support (2008) (6)
Current treatment for thrombotic diseases. (1984) (6)
Lack of Effect of UPD, UDPG, and Glucosamine on Platelet Reactions with Collagen (1974) (6)
Old and new natural products as the source of modern antithrombotic drugs. (1991) (6)
Potential thrombogenicity of angiographic contrast agents. (1991) (6)
Plasma levels of soluble platelet glycoprotein V are linked to fasting blood glucose in patients with type 2 diabetes (2008) (6)
Effects of reserpine on rabbit platelet aggregation and adherence to collagen or injured rabbit aorta. (1977) (5)
Second HLA-A*68 null allele, A*6818 N, identified. (2002) (5)
A Centrifugation Technique for the Preparation of Suspensions of Non Activated Washed Human Platelets (1993) (5)
A randomized study of combined 5-fluorouracil and plasma perfusion over protein A-Sepharose in human advanced colorectal carcinoma (1990) (5)
Capillary Perfusion System for Quantitative Evaluation of Protein Adsorption and Platelet Adhesion to Artificial Surfaces (1987) (5)
Design of clinical trials to evaluate the efficacy of platelet transfusion: The trial for components treated with Helinx[trade ] technology (2001) (5)
Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet‐A light: evaluation of an indicator label (2010) (5)
[Von Willebrand factor in coronary disease]. (1994) (5)
Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strain (2007) (5)
Effect of indomethacin, sulfinpyrazone and dipyridamole on the release of the platelet-derived growth factor. (1979) (5)
RAUWOLFIA DERIVATIVES AND BREAST CANCER (1974) (5)
Effect of insulin on von Willebrand factor release in normal and diabetic subjects: in vivo and in vitro studies. (2001) (5)
[Evolution of techniques for preparation of labile blood products (LBP): pathogen inactivation in LBP]. (2009) (5)
Ultrastructure of adipose tissue in the normal hematopoietic marrow of the rabbit. (1972) (4)
Effect of l‐carnitine during storage of buffy‐coat platelet concentrates in an additive solution (2005) (4)
Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates. (1988) (4)
Methods to study blood-surface interactions (1991) (4)
Evaluation of soluble glycoprotein V as a marker of venous thromboembolism (2011) (4)
Interaction of surfaces and blood cells: platelet reaction (1989) (4)
Potential role of von Willebrand factor in pancreatic venous thrombosis in simultaneous kidney and pancreas transplantation. (1997) (4)
Cored tubules are present in human epidermal Langerhans cells. (2003) (4)
Hemostatic properties and protein expression profile of therapeutic apheresis plasma treated with amotosalen and ultraviolet A for pathogen inactivation (2016) (4)
Platelet functions, α 2-adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of Steinert (1987) (4)
[Gray platelet syndrome]. (1992) (4)
The Effect of Barbituric Acid Derivatives on Platelet Function in Vitro and in Vivo (1973) (4)
ADSORFHON OF HUMAN IgG MOLECULES ONTO GLASS BEADS: REVERSIBLE AND IRREVERSIBLE ASPECTS (1992) (4)
Detection and quantification of secreted soluble Fc gamma RIIA in human sera by an enzyme-linked immunosorbent assay. (1993) (4)
Detection of toxoplasma in aqueous humor by using the polymerase chain reaction. (1992) (4)
Platelet activation revealed by reduced serotonin content in various left ventricular hypertrophic states. (1992) (4)
Internalization by receptor-mediated endocytosis of T6 (CD1 "NA1/34") surface antigen in T6 positive human cord blood cells (Langerhans cell precursors?). (1987) (4)
Sensitivity and long‐term prognostic value of cardiac troponin‐i increase shortly after percutaneous transluminal coronary angioplasty (1998) (4)
BIOLOGICAL CAUSES OF FAMILIAL THROMBOSIS (1988) (4)
[Atherothrombosis: transposition of the models to the clinic and reciprocally]. (2006) (3)
Increased flexibility and liposome‐binding capacity of CD1e at endosomal pH (2011) (3)
Potential thrombogenicity of coronary angioplasty compared with coronary angiography. (1994) (3)
Lipid composition of erythrocytes and thrombocytes of a subantarctic seabird, the king penguin (2000) (3)
[Occurrence of severe, persistent thrombocytopenia following allogeneic bone marrow transplantation, attributable to anti-HPA-1 allo-immunisation of the host]. (2010) (3)
An active hemovigilance program utilizing an EDC system to assess safety of 2994 plasma transfusions prepared with the INTERCEPT Blood System (TM) (2008) (3)
Results from an ongoing hemovigilance program using an electronic data capture system to characterize the safety profile of plasma transfusions prepared with the intercept blood system (TM) (2008) (3)
Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients. (2000) (3)
Platelet Regeneration Time After Aspirin Ingestion and Platelet Survival Time After Labelling with 51Chromium or 111Indium Oxine – A Comparative Study (1985) (3)
[Contribution of gene amplification in the biological diagnosis of toxoplasmosis]. (1994) (3)
[Protein C: importance of its assay in pathology]. (1988) (3)
Rapid and sensitive photometric quantification of the proliferation of adherent vascular endothelial and smooth muscle cells in 96-multiwell plates after may-grünwald giemsa staining. (1987) (3)
[Rapid detection of toxoplasma by "Polymerase Chain Reaction". Contribution to prenatal diagnosis]. (1992) (3)
[Comparative thrombotic risk of two contrast agents in coronary angiography]. (1994) (3)
Polyindolinic Alkaloids from Psychotria forsteriana. Potent Inhibitors of the Aggregation of Human Platelets. (1985) (2)
[Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery]. (1987) (2)
[Platelets and arterial thrombosis]. (2003) (2)
Platelet Adherence to Collagen Containing Surfaces (1977) (2)
Human Adult Endothelial Cell Culture Conditions for Optimal Colonization of Biomaterials Used in Vascular Surgery (1993) (2)
Dehydration of blood platelets by zeodration: in vitro characterization and hemostatic properties in vivo (2015) (2)
[Pathogen inactivation in platelet concentrates: the French experience]. (2011) (2)
Synthesis and biological evaluation of PEG-tirofiban conjugates. (2008) (2)
Inhibition of platelet adherence to damaged vessel wall by drugs. (1977) (2)
Effect of Pentoxifylline on the Modulation by Cytokines of Thrombomodulin and Tissue Factor Activities on the Surface of Human Endothelial Cells in Culture (1990) (2)
[Ethics and transfusion--seminar report]. (2014) (2)
Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages (1992) (2)
S-59 photochemically treated platelets are safe and effective for support of thrombocytopenia Results of the Eurosprite phase 3 trial (2000) (2)
Use of intravenous immunoglobulins (IVIg) to treat a child with pancytopenia and hypoplastic marrow (1992) (2)
An in vitro study of the interactions of plasma proteins with protein A-sepharose CL4B chromatography columns used to remove immunoglobulin G from human plasma. (1986) (2)
Role Of Cyclic Amp In The Inhibition Of Human Platelet Functions By Quercetin, A Flav0N0Id That Potentiates PGI2 Effect (1981) (2)
Transient Adsorption of Fibrinogen from Plasma Solutions Flowing in Silica Capillaries (1995) (2)
Platelet ADP/Purinergic Receptors (1997) (2)
Are CD1a antigens on Langerhans cells empty class I-like molecules that come out in the cold? (1991) (2)
Abstract 4021: Clopidogrel 150 Mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention. Results from the Vasp-02 Randomized Study (2008) (2)
Photochemical Pathogen Inactivation Treatment of Human Plasma (amotosalen + UVA) Has No Major Impact on the Protein expression pattern Assessed by a 2-DIGE Proteomic Assay. (2008) (2)
Production of an Antibody Against Human Protein C and its Use to Detect Patients with Congenital Protein C Deficiency Associated with Thrombosis (1985) (2)
Thrombomodulin activity is found in tissue thromboplastin preparations from placenta and from lung but not from brain. (1987) (2)
Inventory Management (2010) (2)
[Progress in transfusion for storage of platelets]. (2005) (2)
OglIb ~ 3 Integrin Dissociation Induced by EDTA Results in Morphological Changes of the Platelet Surface-connected Canalicular System with Differential Location of the Two Separate Subunits (2002) (2)
Pharmacological Inhibition of the ADP-GP IIb/IIIa-Fibrinogen Pathway of Platelet Aggregation (1991) (2)
[French training program for medical students in transfusion medicine. Transfusion Medicine Teachers' College]. (2005) (1)
Alpha IIB beta 3 integrin dissociation induced by EDTA results in formation of Birbeck granule-like structures in human blood platelets. (1992) (1)
[Congenital deficiencies of natural anticoagulant systems responsible for recurrent thromboembolism]. (1991) (1)
Experimental bone marrow fat necrosis (1977) (1)
[Surgical correction of interventricular communication with pulmonary stenosis in a hemophiliac]. (1983) (1)
Perfusion Technique for in Vitro Evaluation of Platelet Interaction with Biomaterials in Catheter Form (1992) (1)
Abstract 5485: Potent Antithrombotic Activity of EP224283, a Dual Factor Xa Inhibitor and GPIIb-IIIa Antagonist, in Arterial Thrombosis in Mice (2009) (1)
[Bacterial contamination: should it be detected or inactivated?]. (2007) (1)
[Pathogen inactivation technologies: a complex but necessary debate]. (2011) (1)
[Comparative validation of manual and automated methods for mixing and volume control of total blood samples]. (1997) (1)
Retention of Thrombin Generation Capacity of Therapeutic Apheresis Plasma Prepared with Amotosalen and UVA Light (INTERCEPT) Pathogen Inactivation. (2007) (1)
[Importance of disorders of primary hemostasis in the occurrence of upper digestive hemorrhage in cirrhosis]. (1984) (1)
Contribution of nucleic acid amplification techniques to the safety of blood components in France (1998) (1)
Modifications of Platelets that Affect Platelet Adherence to Collagen or Damaged Aorta aud Platelet Survival (1975) (1)
ADP-receptor activation and platelet aggregation (1995) (1)
[Thrombogenic properties of the vessel and their inhibition]. (1982) (1)
Injury to bone-marrow sinusoidal microcirculation. (1972) (1)
PGI2 Production and Effect of Aspirin on Endothelial Cells and Non-Endothelial Cells of the Vessel Wall (1979) (1)
Active Hemovigilance of Pediatric Patients Supported With Plasma Components Prepared With Photochemical Treatment (2009) (1)
[Increased platelet-free calcium concentration in pregnancy hypertension before treatment]. (1989) (1)
Ethnic polymorphism of DXS52 (St 14) locus linked to coagulation factor VIII gene in Argentina. (1990) (1)
[Bone marrow microvascular changes in experimental myelosclerosis (author's transl)]. (1973) (1)
[Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis]. (1989) (1)
[HIV envelope proteins are bound by human epidermal Langerhans cells by a binding site which differs from the site on the CD4 molecule, and are internalized by receptor endocytosis]. (1989) (1)
Type I Glanzmann's thrombasthenia segregates independently of Ss and Duffy systems and the A, B, C, factor B, C2 and C4 loci of the HLA complex. (2008) (1)
DNA amplification of HIV genome in hemophiliacs and in newborns from seropositive mothers (1991) (1)
[Universal implementation of pathogen inactivation in labile blood products is a major step towards transfusion safety]. (2010) (1)
An active hemovigilance program characterizing the safety profile of 7,437 platelet transfusions prepared with. photochemical treatment (INTERCEPT (TM)) (2007) (1)
Platelet-Derived Growth Factor Production During the Platelet Release Reaction Independent of The Endoperoxide Pathway. (1977) (1)
Nucleotide metabolism and ADPase activity in cardiac and renal transplantation. (2000) (1)
Effects of clopidogrel and its inactive form, SR 25989, on plasma, liver and platelet lipids in the rat. (1998) (1)
Platelet activating factor: Regulation by mast cells and aspirin (1984) (0)
Validation Studies in European Blood Centers To Evaluate Processing Whole-Blood-Derived or Apheresis Plasma Using the INTERCEPT Blood System Intended for Commercialization. (2005) (0)
[Antiphospholipid antibodies (aPL): detection and clinical significance]. (1992) (0)
[Isosorbide dinitrate inhibits in vitro platelet aggregation at submicromolar concentrations]. (1992) (0)
[Staff certification for mobile blood collection units]. (1998) (0)
Evaluation of a photo-imageable multilayer thick film technology (1997) (0)
Anti-Phospholipid Autoantibodies in Thrombosis: Cause and/or Consequence of the Disruption of the Protein C-Dependent Hemostatic Balance (2020) (0)
[Hemolytic anemia induced by penicillin during agranulocytosis with plasmocytic reaction of the bone marrow. Apropos of a case. Review of the literature]. (1973) (0)
4.P.6 Persistent endothelial injury in post-transplantation arteriosclerosis is related to histoincompatibility, in a manner independent of peritransplantation trauma (1997) (0)
[Apropos of certain toxic effects of L-asparaginase in human therapy]. (1971) (0)
POINT MUTATIONS PRODUCING TYPE-1A ANTITHROMBIN-III DEFICIENCY (1991) (0)
DETECTION RAPIDE DE TOXOPLASMES PAR LA POLYMERASE CHAIN REACTION UN APPORT AU DIAGNOSTIC ANTENATAL (1992) (0)
Reticulocytes and solvents: an epidemiological study. (1999) (0)
Inherited homozygous TAP2 peptide transporter defect in two siblings with HLA class I deficiency (1994) (0)
Angiogenesis inhibitor SR 25989 upregulates thrombospondin‐1 expression in human vascular endothelial cells and foreskin fibroblasts (1997) (0)
A NewVariant of Glanzmann ' s Thrombasthenia ( Strasbourg I ) Platelets with Functionally Defective Glycoprotein llb-Illa Complexes and a Glycoprotein Ilia 214 Arg-214 Trp Mutation (2013) (0)
How dietary (n-3) fatty acids from marine sources affect haemostasis and thrombosis. (2000) (0)
Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review (2013) (0)
Medicinal composition containing tetrahydrothienopyridine derivative (1992) (0)
Coagulation Factors in Therapeutic Apheresis Plasma Held for 18 Hours at Ambient Temperature Prior to Pathogen Inactivation (INTERCEPT (2006) (0)
Use of tetrahydrothienopyridinderivater as inhibitors of angiogenesis (1992) (0)
Letter: Rauwolfia derivatives and breast cancer. (1974) (0)
[Improvement in medical education. The Canadian solutions. I. Better defined objectives]. (1973) (0)
Use of beta-naphthoquinone derivatives to accelerate the growth of endothelial cells and inhibit NO synthetases (1994) (0)
[Is the neuroleptic malignant syndrome comparable to anesthesia-induced malignant hyperthermia?]. (1986) (0)
Activation of Phosphoinositide 3-Kinase Aggregation Induced by the PAR1-Activating Peptide Through the Late A Key Role of Adenosine Diphosphate in the Irreversible Platelet (2013) (0)
Subtractive Hybridization Ligation of Atopic Monocytes Identified by RI ε Kinetics of Gene Induction After (2002) (0)
Platelet Deposition on Biomaterials measured with a Capillary Perfusion Model (1993) (0)
Using Tetrahydrothienopyridinderivate as angiogenesis inhibitors. (1992) (0)
[In vivo and invitro methods of studying platelet adhesion to the components of the vascular wall]. (1979) (0)
2.P.341 Effect of dietary saturated, oleic and n-3 fatty acids on acute collagen-induced thrombus formation in rats (1997) (0)
[Pathogen inactivation in labile blood products: transfusion safety and economic impact]. (2006) (0)
Adjustable filter RF planar technology and process filter setting (2012) (0)
[Role of blood platelets in thrombosis of the arteries and artificial surfaces]. (1987) (0)
[Plasma-derived products: therapeutic biological products]. (1997) (0)
[Anuria, cholestatic jaundice, thrombocytopenia, hemolysis. Immunoallergic complication due to ajmaline]. (1985) (0)
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology]. (1992) (0)
Fc gamma RII/CD32-negative human Langerhans cells may be responsible for the immunostimulatory activity of freshly isolated epidermal cells. (1992) (0)
In Vitro Validation of the S-303 Treatment System (2012) (0)
[Evaluation of measurements intended to develop regularity of blood donation]. (1998) (0)
Global Optimization of MCMs with ASICs Using Concurrent Engineering (1994) (0)
Filter adjustable radio frequencies in coplanar technology and filter the adjustment method (2011) (0)
[Quality control of homologous blood collection activities: 5 years' experience]. (1998) (0)
with megakaryocyte-restricted MYH9 inactivation Abnormal megakaryocyte morphology and proplatelet formation in mice (2013) (0)
[Mechanisms of platelet activation and development of antiplatelet agents]. (1996) (0)
The platelet, its role and function (1989) (0)
α of platelet glycoprotein Ib binding site within the cytoplasmic tail ζ Identification of a novel 14-3-3 (2013) (0)
Mutation in CD 1 e Impairs Lipid Antigen Cutting Edge : A Naturally Occurring (2008) (0)
Modifications des facteurs de l'hémostase. Discussion (1993) (0)
Évaluation in vitro du procédé d’inactivation des concentrés de globules rouges par intercept-RBC (2013) (0)
Quantitative Platelet Aggregation In Vitro (1993) (0)
Filtering Capacitor Embedded in LTCC Substrate for RF and Microwave Applications (2007) (0)
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids]. (1985) (0)
Lipid A from gram-negative bacteria is detectable in neonatal and adult erythrocyte membranes (1998) (0)
[Platelet-vessel interactions]. (1981) (0)
037 - The relative contribution of the CYP2C19*2 polymorphism in the low responsiveness to clopidogrel in the VASP-02 study (2010) (0)
[In vivo and in vitro methods of studying platelet adhesion to the components of the vascular wall]. (1979) (0)
O498 – Intracellular pathway of MHC class II molecules in human dendritic cells (1996) (0)
[Improving medical education. The Canadian solutions. II. More suitable methods]. (1973) (0)
A Randomized Study of On-Line Plasma Perfusion over Protein A-Sepharose and 5-Fluorouracil Chemotherapy in Patients with Metastatic Colorectal Carcinoma (1991) (0)
[Effect of E coli or Erwinia asparaginase and corticotherapy on fibrinogen concentration in induction of acute lymphoblastic leukemia in children]. (1994) (0)
An Active Hemovigilance Program To Characterize the Safety Profile of 16,631 Platelet Components Prepared With Photochemical Pathogen Inactivation Treatment Transfused in Routine Clinical Practice (2009) (0)
Immunological status in two siblings with a peptide transporter deficiency (1994) (0)
[Platelet concentrates: types, costs and indications]. (1994) (0)
Hb Tsukumi [beta117(G19)His-->Tyr] found in a Moroccan woman. (2001) (0)
Coagulation Factor Activity in Therapeutic Plasma Prepared from Whole Blood with Pathogen Inactivation (INTERCEPT ™ ) Treatment. (2006) (0)
in human platelets generation 2 Adenosine diphosphate (ADP) does not induce thromboxane A (2011) (0)
Plasma Fibronectin: Its Dosage in Clinical Biology (1982) (0)
To the editor : Adenosine diphosphate ( ADP ) does not induce thromboxane A 2 generation in human platelets (0)
and aggregation Platelet glycoprotein V binds to collagen and participates in platelet adhesion (2013) (0)
Inactivation of Infectious CMV in Platelet Products: Comparison of INTERCEPT Blood System™ and Leukofiltration. (2007) (0)
[Microvascularization of femoral bone marrow in the rabbit]. (1971) (0)
DETECTION AND EFFECTS OF THROMBOMODULIN ACTIVITY IN CRUDE THROMBOPLASTIN PREPARATIONS FROM PLACENTA AND LUNG (1987) (0)
Interconnect apparatus for electronic circuits, particularly microwave circuits of electronic (2009) (0)
Évaluation de l’identification d’anticorps anti érythrocytaire sur l’automate Galileo Immucor (2013) (0)
[Comparative study of the regeneration of the microcirculation of rabbit femur bone marrow after curetage and at the time of experimental myelosclerosis]. (1977) (0)
[Endothelial adhesion and effraction by human MCF-7 mammary tumor cells. Morphological and quantitative study in culture]. (1984) (0)
Isoforms in Human Dendritic Cells Adhesive and / or Signaling Functions of CD 44 (1998) (0)
Use of beta-Naphthochinonderivaten to accelerate the proliferation of endothelial cells and inhibition of NO synthases (1994) (0)
Management of plasmapheresis in France. (1996) (0)
[Blood platelets: conclusion]. (2013) (0)
Hb TSUKUMI [β117(G19)His →Tyr] FOUND IN A MOROCCAN WOMAN (2001) (0)
Thrombin Cleavage Megakaryocyte-Specific Promoters and Demonstration of Functional Gene Cloning of Rat and Mouse Platelet Glycoprotein V: Identification of (2013) (0)
Photopheresis with Oral Psoralen and UV-A : Effects on Haemostasis(Rheology and Photopheresis) (1996) (0)
[Arterioarterial shunt coated with collagen. A model of acute arterial thrombosis for testing antithrombotic agents in rats]. (1991) (0)
Free communication 9: Venous thrombosisThe effect of phospholipids on purified human endothelial thrombomodulin (1986) (0)
Abstract 5303: Tenascin-c Supports Human Blood Platelet Adhesion and Activation Under Both Static and Flow Conditions (2009) (0)

This paper list is powered by the following services:

Jeanne-pierre Cazenave's Academic­Influence.com Rankings

Jeanne-pierre Cazenave's Degrees

Why Is Jeanne-pierre Cazenave Influential?

Jeanne-pierre Cazenave's Published Works

Published Works

Jeanne-pierre Cazenave's AcademicInfluence.com Rankings